RecallRadar

FDA Drug recall D-0787-2021

Clopidogrel Tablets, USP, 75 mg, 500-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured…

On 2021-09-08 the FDA classified a Class II recall of Clopidogrel Tablets, USP, 75 mg, 500-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured… by Macleods Pharma Usa, citing presence of foreign matter.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0787-2021
ClassificationClass II
Statusterminated
Initiated2021-08-02
Published2021-09-08
Last updated2026-09-13 11:52 UTC
CompanyMacleods Pharma Usa
DistributionUS

Product

Clopidogrel Tablets, USP, 75 mg, 500-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceutical Ltd., Baddi, Himachal, Pradesh, INDIA NDC 33342-060-15

Reason

Presence of foreign matter

Identifiers

ndc33342-060-07
ndc33342-060-15
ndc33342-060-12
ndc33342-060-10
ndc33342-060-44
code_infoLot # BCA82021A, Exp 06/2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0787-2021%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.